Katumi Ikeda
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Katumi Ikeda.
Clinical and Experimental Pharmacology and Physiology | 1993
Minoru Adachi; Yasuo Nara; Masayuki Mano; Katumi Ikeda; Ryoichi Horie; Yukio Yamori
1. Free Ca2+ ([Ca2+]i) and Mg2+ ([Mg2+]i) were measured in peripheral lymphocytes from stroke‐prone spontaneously hypertensive rats (SHRSP) and normotensive Wistar‐Kyoto rats (WKY) at the age of 5, 7 and 17 weeks, from various antihypertensive agents‐treated SHRSP, and from secondary hypertensive WKY.
Clinical and Experimental Pharmacology and Physiology | 1994
O. G. Gutierrez; Katumi Ikeda; Yasuo Nara; G. U. Deguan; Yukio Yamori
1. Dietary 0.023%NG‐nitro‐L‐arginine (L‐NNA), an inhibitor of nitric oxide synthesis, induced hypertension in normotensive Wistar‐Kyoto rats (WKY). This hypertension was significantly attenuated in WKY given a fish protein‐rich diet.
Clinical and Experimental Pharmacology and Physiology | 2000
Kenichi Mizutani; Katumi Ikeda; A Ishikado; Yasuhiro Kawai; Yukio Yamori
1. The effect of food collagen, cattle bone collagen‐derived (CBC) peptides, on ovariectomy induced increases in blood pressure was examined in stroke‐prone spontaneously hypertensive rats (SHRSP).
Clinical and Experimental Pharmacology and Physiology | 1999
Yasuo Nara; Tomoji Mashimo; Tomoko Tamada; Chiho Matsumoto; Yuji Ishinaga; Katumi Ikeda; M Sawamura; Yukio Yamori
1. Linkage analysis is performed between basal or salt‐ sensitive high blood pressure and several loci on chromosomes in F2 progenies obtained from crossing stroke‐prone spontaneously hypertensive rats (SHR) and normotensive Wistar‐Kyoto rats.
Clinical and Experimental Pharmacology and Physiology | 1991
Katumi Ikeda; Yasuo Nara; Yukio Yamori
1. To determine the effect of chloride ion on the development of hypertension and the incidence of cerebral lesions in stroke‐prone spontaneously hypertensive rats (SHRSP), groups of 10 rats were administered chronically with either 171 mmol/L sodium chloride or equimolar sodium provided as sodium citrate in the drinking water from the age of 12 weeks.
Clinical and Experimental Pharmacology and Physiology | 1985
H. Wang; Katumi Ikeda; Masahiro Kihara; Yasuo Nara; Ryoichi Horie; Yukio Yamori
1. Stroke‐prone spontaneously hypertensive rats (SHRSP) and stroke‐resistant SHR (SHRSR) exhibited an increased preference for a 2% NaCl solution, relative to water, in comparison with normotensive Wistar‐Kyoto (WKY), but the preference was lost quickly in SHRSP with unbroken exposure.
Clinical and Experimental Pharmacology and Physiology | 1995
Nanfang Li; Makoto Sawamura; Yasuo Nara; K. Kizawa; Katumi Ikeda; H. Usui; K. Kurahasi; Yukio Yamori
1. To investigate the effect of endogenous cholesterol synthesis on blood pressure and vascular response, a HMG CoA reductase inhibitor, pravastatin (1 or 10 mg/kg) was administered orally for 2 or 4 weeks to 8–13 week old spontaneously hypertensive rats (SHR/Izm) and normotensive Wistar‐Kyoto (WKY/Izm) rats.
Clinical and Experimental Pharmacology and Physiology | 1995
Yasuo Nara; Katumi Ikeda; Chiho Matsumoto; Makoto Sawamura; Yukio Yamori
Japanese Heart Journal | 1995
Satoshi Fukuda; Haruzo Iida; Satoru Tuschikura; Katumi Ikeda; Yasuo Nara; Yukio Yamori
Japanese Heart Journal | 1998
Keita Ueno; Norihiro Kato; Tomoji Mashimo; Katumi Ikeda; Makoto Sawamura; Yukio Yamori